Home » Poster-Abstracts

Poster-Abstracts

Abstracts Poster Session: 2nd – 3rd October 2024 in the foyer and terrace (1st floor)


E-Poster

Poster NumberTitleDownload
P01Study of the microbiological recontamination of anticancers drug vials in a controlled atmosphere areaDownload
P02Enhancing patient care by working on high-turnover drugs: the experience of an Italian oncology instituteDownload
P03Use of a semi-robotic system in chemotherapy setups: the means of a safety medical setupDownload
P04GMP Annex 1 Revision 2022 – Impacts on the patient-specific preparation of parenterals in pharmaciesDownload
P06Efficient and flexible system for the prescription and preparation of parenteral nutrition admixtures for pediatric oncology patientsDownload
P07Impact of advanced medical validation and telemonitoring on the delivery delay of chemotherapy bags to patients at Saintes HospitalDownload
P10Evaluation of Active Ingredient Losses in 86 Chemotherapy Patients: A Prospective Study at Le Dantec University Hospital in SenegalDownload
P13Room of errorsDownload
P14Evaluation of the logistics management of anticancer drugs at the central pharmacy of Aristide Le Dantec Hospital in Dakar: retrospective study using the IMAT toolDownload
P15Economic  impact  of centralization of chemotherapy preparation: Experience of the National  hospital of Aristide le dantec, Dakar senegalDownload
P17Validation of the BCP-CHEMO backup tool as part of a business continuity plan for a centralized chemotherapy reconstitution unit: simulation and preliminary risk analysisDownload
P18Surface contamination by cytotoxic products : comparative of two methods of packaging chemotherapy preparationsDownload
P21Exploring the Potential of Myeloid Suppressor Cells in Personalized OncologyDownload
P25Efficacy and safety of ruxolitinib in glucocorticoid-refractory acute graft-versus-host disease in a terciary hospitalDownload
P28Study of risk factors related to hypersensitivity reactions induced by ChemotherapyDownload
P29Efficacy and safety of mogamulizumab for cutaneous T-cell lymphoma: a single-center experienceDownload
P30Overall Survival in Patients with Metastatic Castration Sensitive Prostate Cancer Treated With Apalutamide versus Abiraterone Acetate – A Head-to-Head Analysis of Real-World Patients in the United StatesDownload
P32APALUTAMIDE EFFECTIVENESS AND SAFETY: REAL-WORLD DATA IN METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (mHSPC) IN SPAINDownload
P33REAL-LIFE EFFECTIVENESS AND SAFETY OF PARPis IN FIRST-LINE MAINTENANCE OVARIAN CANCERDownload
P34Cancer therapy related cardiovascular adverse events and toxicity in individuals receiving systemic anti-cancer therapy with anthracycline chemotherapy, HER2-targeted therapies and immune checkpoint inhibitorsDownload
P35IMPACT OF COVID-19 PANDEMIC ON SMALL-CELL LUNG CANCER (SCLC): OBSERVATIONAL RETROSPECTIVE STUDY IN A HOSPITAL IN NORTHEN ITALYDownload
P36Indirect Survival Analysis of Patients with Melanoma: The Impact of Adjuvant TherapyDownload
P37Fruquintinib: The first Portuguese caseDownload
P38The Prophylactic Effect of Different Hydration Regimens on the Toxicity of High-Dose Cyclophosphamide in Hematologic Malignancies (HYDRA-CYC)Download
P39Associations between hydration regimen and cisplatin dose-limiting toxicity in patients with head and neck squamous cell carcinoma requiring chemoradiationDownload
P40Real world patient outcomes on the efficacy of lanreotide treatment for neuroendocrine tumors: the influence of BMI, BSA and renal functionDownload
P41Real-World Evaluation of Abiraterone Acetate and Enzalutamide in mCRPC: Comparative Safety and EffectivenessDownload
P42EFFICACY AND SAFETY OF PEMBROLIZUMAB IN COMBINATION WITH LENVATINIB IN THE TREATMENT OF ENDOMETRIAL CARCINOMADownload
P43Management of venetoclax ramp-up schedule and tumor lysis syndrome monitoring: a real-world retrospective study in CLL in university hospitalDownload
P44Real-world experience of use, safety and effectiveness of methadone for cancer pain : retrospective study in french university hospitalDownload
P46Olaparib desensitazion protocol in patient with breast cancer – literature review and clinical case follow upDownload
P47Clinical pharmacist provided patient counseling to pediatric oncology outpatient at children cancer hospital 57357 may reduce medication errorsDownload
P49Investigating the extent of comorbidity in a cohort of patients with cancer in a resource limited settingDownload
P51DRUG-DRUG INTERACTIONS BETWEEN ORAL ANTICANCER AGENTS AND GASTRIC ANTISECRETORY DRUGS: BUILDING A VISUAL AND SYNTHETIC TOOLDownload
P52Enhancing patient guidance on oral oncolytic drugs in primary care in Belgium: a multidisciplinary collaboration between general practitioners and community pharmacistsDownload
P54The Irish Haematology Oncology Podcast: A Novel Educational Tool for Healthcare ProfessionalsDownload
P55Pharmaceutical Consultations in Metastatic Breast Cancer: Drug-Related Problems and InterventionsDownload
P56Assessment of the global status quo on oral cancer drugs: a multinational surveyDownload
P59Clinical Pharmacist’s role in Oncology at a University Hospital in southern Brazil: assessment of the impact of an artificial intelligence toolDownload
P60REAL-PRACTICE ANALYSIS OF POSSIBLE ANTIBIOTIC INTERACTIONS IN PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS (ICIS)Download
P61Pharmacist Interventions on Drug-Related Problems in a Onco-Haematology Department: A Prospective StudyDownload
P62Implementation and evaluation of clinical pharmacy activities in an oncology clinical trials departmentDownload
P63Study of Adherence to Tyrosine Kinase Inhibitors in Patients Diagnosed with Chronic Myeloid Leukemia: Preliminary Results of a Retrospective CohortDownload
P64Pharmaceutical analysis of the use of complementary therapies in a cohort of pediatric French transplanted patientsDownload
P67Management of nephrotoxicity induced by cisplatin: Standardization of a center’s hydration protocolDownload
P71The role of the clinical pharmacist in the treatment management for breast cancer patients treated with oral therapyDownload
P72THE ROLE OF MEDICATION RECONCILIATION IN A MEDICAL ONCOLOGY DEPARTMENTDownload
P73Predictive factors for delayed elimination in diffuse large B-cell lymphoma patients treated with high-dose methotrexate: A bicentric french study focusing on hypoalbuminemiaDownload
P76DOSE MODIFICATION OF ABEMACICLIB, PALBOCICLIB AND RIBOCILCIB: A RETROSPECTIVE STUDYDownload
P78Inter-professional database to improve adherence to oral anticancer drugsDownload
P79Implementation of a protocol for the renewal and adaptation of oral therapy prescriptions by oncology pharmacistsDownload
P81Assessment of Knowledge, Attitude, and Practice towards Cardiology Pharmacy Service at the Children’s Cancer Hospital Egypt 57357Download
P82Clinical impact of pharmaceutical care in a multidisciplinary program for the management and safety of bispecific antibody therapy in haematological malignanciesDownload
P83ENHANCING PATIENT CARE: IMPLEMENTING A PHARMACEUTICAL SUPPORT CIRCUIT IN HEMATO-ONCOLOGYDownload
P84THE ROLE OF CLINICAL PHARMACIST IN ADHERENCE TO IMATINIB TREATMENTDownload
P85Oral Cancer Treatment administration: Whole or crushed?Download
P86Azacitidine-venetoclax posology and toxicity in acute myeloid leukemia patients who relapsed after allogeneic hematopoietic stem cell transplantationDownload
P87Real world prospective analysis of the efficacy of counseling and structured patient information in improving safety of care and pharmacological therapy adherence in oncologyDownload
P88Medication Shelf Life Extension Proposal for the Public Health Institutions in South AfricaDownload
P89Compatibility Evaluation of subcutaneous applicated solution in palliative careDownload
P91Search for physicochemical incompatibilities of anticancer drugs after reconstitutionDownload
P92Screening for DPD deficiency is mandatory before capecitabine exposure: what about community pharmacies?Download
P94Comparative Analysis of Traditional, Manually and AI-enhanced Oral Oncology Medication Patient Information – A Pilot StudyDownload
P97Lifecycle assessment of the preparation of injectable anticancer drugs in a pharmaceutical preparation unitDownload
P98Early stages of clinical trials implementation in onco-hematology: a risk analysis in a cytotoxic preparation unitDownload
P99Retrospective evaluation of TEMOZOLOMIDE appropriate prescription based on body surface area in neuro-oncology pathways of a French comprehensive cancer centreDownload
P100Use of cytotoxics in paediatric oncology in Algeria: Results of a survey of healthcare professionalsDownload
P103Pharmacotherapeutic monitoring of cellular immunotherapiesDownload
P104ESOP’s yellow hand: do professionals know it?Download
P113Use of Busulfan and Treosulfan in a Regional University Hospital CenterDownload
P114Bacterial Resistance to Antibiotics in Pediatric Oncohaematology Department of a Hospital in Algiers, AlgeriaDownload
P115Development of an educational game for ongoing staff trainingDownload
P116Environmental impact of oncology drugs after administration: analysis and evaluations of the best-selling drugs in ItalyDownload
P120“Think Different” Healthcare: Beyond Costs to Strategic InvestmentsDownload
P122STUDY OF THE COST OF NON-COMPLIANT TOCILIZUMAB PRESCRIPTIONS IN PATIENTS TREATED WITH CAR-T CELLSDownload
P124MULTIDIMENSIONAL ASSESSMENT (MINI-HTA) BETWEEN INTRAVENOUS AND SUBCUTANEOUS FORMULATION OF PERTUZUMAB AND TRASTUZUMAB IN THE TREATMENT OF HER2+ BREAST CANCERDownload
P128Dose adjustment of 5-FU in patients with partial DPD deficiencyDownload
P129Pharmacogenetics profiling and Therapeutic Drug Monitoring as a new approach to treat locally advanced/metastatic HR+/HER2- breast cancerDownload
P130The use of therapeutic drug monitoring to personalize once-daily intravenous busulfan in Thai pediatric patients underwent hematopoietic stem cell transplantationDownload
P134Impact of Lab Pharmacist Phone Call Service on The Accuracy of Voriconazole Therapeutic Drug Monitoring Levels of Outpatient in Pediatric Oncology Setting A prospective StudyDownload
P135DETERMINATION AND PHARMACOKINETIC INTERPRETATION OF 5-FLUOROURACIL PLASMA LEVELS IN COLORECTAL CANCER PATIENTSDownload
P136Improvement of a Clinical Decision Support System (CDSS) For Voriconazole (VCZ) Therapeutic Drug Monitoring (TDM) and Dosing in Pediatric Oncology SettingDownload

Corner Sessions: 3rd October (10:30-11:00 and 15:30-16:00)


Oral Communications: 4th October (08:30-10:00)